Literature DB >> 17962480

Association between multifocal ERG implicit time delays and adaptation in patients with diabetes.

Kevin W Bronson-Castain1, Marcus A Bearse, Ying Han, Marilyn E Schneck, Shirin Barez, Anthony J Adams.   

Abstract

PURPOSE: Local first-order multifocal electroretinogram (mfERG) implicit time (K1-IT) delays have proved to be important and predictive indicators of retinal function in diabetes. To better understand the nature of these delays, the authors examined the spatial association between K1-IT and second-order amplitudes (K2-SNR; a measure of adaptation) in diabetic and control subjects.
METHODS: The authors studied K1-IT, K1 amplitude, and K2-SNRs of responses from 35 retinal zones. These were recorded from 20 diabetic patients without retinopathy, 20 patients with mild to moderate nonproliferative diabetic retinopathy (NPDR), and 30 healthy control subjects. The K1-IT and K2-SNR measurements were then adjusted according to normative and subject median values to reduce or remove the effects of retinal location, intersubject differences, and abnormally small K1 amplitudes.
RESULTS: There was no significant association between K1-IT and K2-SNR in the control group (P > 0.05) and only a marginal association in the NoRet group (P = 0.05). In contrast, longer K1-ITs were significantly associated with reduced K2-SNRs in NPDR subjects (P < 0.01). In the NPDR eyes, zones without retinopathic lesions showed a significant association between K1-IT and K2-SNR (P < 0.01).
CONCLUSIONS: The results suggest that an association between longer K1-IT and reduced K2-SNR (abnormal adaptation) develops after the appearance of NPDR, but this association does not depend on the presence of colocalized retinopathic lesions.

Entities:  

Mesh:

Year:  2007        PMID: 17962480      PMCID: PMC2709819          DOI: 10.1167/iovs.07-0180

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  39 in total

1.  Imaging visual function with the multifocal m-sequence technique.

Authors:  E E Sutter
Journal:  Vision Res       Date:  2001       Impact factor: 1.886

2.  Multifocal ERG findings in complete type congenital stationary night blindness.

Authors:  M Kondo; Y Miyake; N Kondo; A Tanikawa; S Suzuki; M Horiguchi; H Terasaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-05       Impact factor: 4.799

3.  Glial cell inhibition of neurons by release of ATP.

Authors:  Eric A Newman
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

4.  Effects of APB, PDA, and TTX on ERG responses recorded using both multifocal and conventional methods in monkey. Effects of APB, PDA, and TTX on monkey ERG responses.

Authors:  William A Hare; Hau Ton
Journal:  Doc Ophthalmol       Date:  2002-09       Impact factor: 2.379

5.  High-affinity GABA uptake in retinal glial (Müller) cells of the guinea pig: electrophysiological characterization, immunohistochemical localization, and modeling of efficiency.

Authors:  Bernd Biedermann; Andreas Bringmann; Andreas Reichenbach
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

6.  Retinal origins of the primate multifocal ERG: implications for the human response.

Authors:  Donald C Hood; Laura J Frishman; Shannon Saszik; Suresh Viswanathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

7.  Glial reactivity, an early feature of diabetic retinopathy.

Authors:  E Rungger-Brändle; A A Dosso; P M Leuenberger
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

8.  Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.

Authors:  A J Barber; D A Antonetti; T W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

9.  Multifocal oscillatory potentials in type 1 diabetes without retinopathy.

Authors:  A Kurtenbach; H Langrova; E Zrenner
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

10.  Kir potassium channel subunit expression in retinal glial cells: implications for spatial potassium buffering.

Authors:  Paulo Kofuji; Bernd Biedermann; Venkatraman Siddharthan; Maik Raap; Ian Iandiev; Ivan Milenkovic; Achim Thomzig; Rüdiger W Veh; Andreas Bringmann; Andreas Reichenbach
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

View more
  7 in total

1.  Structural neurodegeneration correlates with early diabetic retinopathy.

Authors:  Ulrik Frydkjaer-Olsen; Rasmus Soegaard Hansen; Tunde Peto; Jakob Grauslund
Journal:  Int Ophthalmol       Date:  2017-07-21       Impact factor: 2.031

Review 2.  Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.

Authors:  Marcus A Bearse; Glen Y Ozawa
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 3.  An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI).

Authors:  Muhammad Usman
Journal:  Cureus       Date:  2018-07-30

Review 4.  Impacts of high fat diet on ocular outcomes in rodent models of visual disease.

Authors:  Danielle A Clarkson-Townsend; Amber J Douglass; Anayesha Singh; Rachael S Allen; Ivie N Uwaifo; Machelle T Pardue
Journal:  Exp Eye Res       Date:  2021-01-11       Impact factor: 3.467

5.  Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.

Authors:  Marc Baget-Bernaldiz; Pedro Romero-Aroca; Angel Bautista-Perez; Joaquin Mercado
Journal:  Doc Ophthalmol       Date:  2017-08-04       Impact factor: 2.379

6.  Multifocal Electroretinogram Alterations after Intravitreal Ranibizumab Treatment in Diabetic Macular Edema.

Authors:  Sema Tamer Kaderli; Dicle Hazirolan; Guner Uney; Ahmet Kaderli; Nurten Unlu; Mehmet Akif Acar; Firdevs Ornek
Journal:  Beyoglu Eye J       Date:  2022-02-18

7.  Differences in Multifocal Electroretinogram Study in Two Populations of Type 1 and Type 2 Diabetes Mellitus Patients without Diabetic Retinopathy.

Authors:  Pedro Romero-Aroca; Raul Navarro-Gil; Gibet Benejam; Montse Vizcarro; Marc Baget-Bernaldiz
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.